Schröder, E., and Liibke, K.: The Peptides. Vol. II. Synthesis, occurrence, and action of biologically active polypeptides, p. 281. Academic Press, New York, 1966.
2.
Boissonnas, R.A., Guttmann, St. , Berde, B., and Konzett, H.: Relationships between the chemical structures and the biological properties of the posterior pituitary hormones and their synthetic analogues. Experientia, 17: 377, 1961.
3.
Rudinger, J.: Synthetic analogues of oxytocin with inhibitor activity or protracted action . Proc. Second Int. Congress Endocrinology, Excerpta Medica Int. Congress Series, No. 83: 1202, 1964.
4.
VanDyke, H. B., Adamsons, Jr., K., and Engel, S. L.: Aspects of the biochemistry and physiology of the neurohypophyseal hormones. Rec. Prog. Hormone Res., 11: 1, 1955.
Berde, B., and Cerletti, A.: Medizinische und biologische Aspekte von pharmakologischen Arbeiten mit synthetischen Peptiden von neurohypophysärem Typus. Klin. Wschr., 23: 1159, 1964.
7.
Orloff, J., and Handler, J.S.: Vasopressin-like effects of adenosine 3,5'-phosphate (cyclic 3',5'-AMP) and theophylline in the toad bladder. Biochem. and Biophys. Res. Communs.,5: 63, 1961.
8.
Schwartz, I.L., Rasmussen, H., Marc-Aurelle, J., and Christman, D.: Molecular phenomena related to mechanism of action of vasopressin on membrane permeability. In The biochemical aspects of hormone action , edited by A. B. Eisenstein. p. 66. Little, Brown and Co., Boston, 1964.
9.
Krogh, A.: The anatomy and physiology of capillaries. Yale Univ. Press , New Haven, 1929.
10.
Altura, B.M. , Hsu, R., Mazzia, V.D.B., and Hershey , S.G.: Influence of vasopressors on survival after traumatic, intestinal ischemia and endotoxin shock. Proc. Soc. Exptl. Biol. Med., 119: 389, 1965.
11.
Hershey, S.G. , Mazzia, V.D.B., Altura, B.M., and Gyure, L.: Effects of vasopressors on the microcirculation and on survival in hemorrhagic shock. Anesthesiology, 26: 179, 1965.
12.
Hershey, S.G. , and Altura, B.M.: Manipulation of the peripheral circulation with vasoactive drugs in the management of shock: A microcirculatory basis for therapy. Schweiz. med. Wschr., 96: 1467 and 1516, 1966 (2 parts).
13.
Altura, B.M. , Hershey, S.G., and Mazzia, V.D.B.: Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock. Am. J. Surgery , 111: 186, 1966.
14.
Altura, B.M. , and Hershey, S.G.: Effects of vasoactive drug therapy on microvascular injury in shock. Pharmacologist, 7: 144, 1965.
15.
Zweifach, B.W. , and Metz, D.B.: Rat mesoappendix procedure for bioassay of humoral substances acting on peripheral blood vessels. Ergebn. Anat. Entwichlungsgesch.,35: 175, 1956.
16.
Altura, B.M., and Zweifach, B.W.: Antihistamines and vascular reactivity. Am. J. Physiol., 209: 545, 1965.
17.
Altura, B.M., Hershey, S.G., and Zweifach, B.W.: Effects of a synthetic analogue of vasopressin on vascular smooth muscle. Proc. Soc. Exptl. Biol. Med., 119: 258, 1965.
18.
Altura, B.M.: Differential actions of polypeptides and other drugs on coronary inflow vessels . Am. Heart J., 72: 709, 1966.
19.
Katsoyannis, P.G.: Oxypressin, a synthetic octapeptide amide with hormonal properties. J. Am. Chem. Soc., 79: 109, 1957.
20.
Katsoyannis, P.G., and du Vigneaud , V.: The synthesis of the histidine analogue of the vasopressins. Arch. Biochem. Biophys. , 78: 55, 1958.
21.
Boissonnas, R.A.: The chemistry of oxytocin and vasopressin. In Polypeptides which affect smooth muscles and blood vessels, edited by M. Schachter. p. 16. Pergamon Press, New York, 1960.
22.
Lipton, B., Hershey, S.G., and Baez, S.: Compatibility of oxytocics with anesthetic agents. J. Am. Med. Assoc., 179: 410, 1962.
23.
Baez, S., and Orkin, L.R.: Effects of anesthetics on the response of the microcirculation to circulating humors. Anesthesiology, 24: 568, 1963.
24.
Furchgott, R.F.: The pharmacology of vascular smooth muscle . Pharmacol. Rev., 7: 183, 1955.
25.
Somlyo, A.V. , Woo, C., and Somlyo, A.P.: Effect of magnesium on posterior pituitary hormone action on vascular smooth muscle. Am. J. Physiol. , 210: 705, 1966.
26.
Dale, H.H.: Some chemical factors in the control of the circulation. Lancet, 1179, 1929.
27.
Bartelstone, H.J., and Nasmyth, P.A.: Vasopressin potentiation of catecholamine actions in dog, rat, cat and rat aortic strip. Am. J. Physiol. , 208: 745, 1965.
28.
Altura, B.M.: Use of pharmacologic antagonists to evaluate humoral regulation of the microcirculation . Proc. 4th European Conference on Microcirculation , Cambridge, England, 1966. (to be published by S. Karger).
29.
Altura, B.M. : Evaluation of neuro-humoral substances in local regulation of blood flow. Amer. J. Physiol., in press.
30.
Berde, B.: Some observations on the circulatory effects of oxytocin, vasopressin and similar polypeptides. In Advances in oxytocin research, edited by J. H. M. Pinkerton. p. 11. Pergamon Press, New York, 1965.
31.
Cort, J.H., Hammer, J., Ulrych, M., Píša, Z., Douša, T., and Rudinger, J.: Synthetic extended-chain analogues of vasopressin and oxytocin in the treatment of experimental hemorrhagic shock. Lancet, 840, 1964.
32.
Pickford, M.: Effects of neurohypophyseal hormones on the vascular system. In Oxytocin, vasopressin and their structural analogues, edited by J. Rudinger. p. 31. Pergamon Press, New York, 1964.
33.
Lloyd, S.M.: Mode of action of oxytocin on blood vessels. In Oxytocin, vasopressin and their structural analogues, edited by J. Rudinger. p. 37. Pergamon Press, New York, 1964.
34.
Heller, H.: Inactivation of vasopressin and oxytocin in vivo. In Polypeptides which affect smooth muscles and blood vessels, edited by M. Schachter. p. 59. Pergamon Press, 1960.
35.
Ginsburg, M.: Fate and transport of neurohypophyseal hormones. In Oxytocin, vasopressin and their structural analogues, edited by J. Rudinger. p. 87. Pergamon Press, New York, 1964.
36.
Sawyer, W.H.: Neurohypophysial peptides and water excretion in the Vertebrates. In Hormones and the kidney, edited by P. C. Williams. p. 54. Academic Press, New York, 1963.
37.
Zweifach, B.W. : Functional behavior of the microcicrculation . Charles C Thomas, Springfield , 1961.
